Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer

March 31, 2020 Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer

The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …
News
shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020 Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
News
medications-257333_640

People or profit: What is the best system to regulate drug prices?

March 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
Feature
flag_of_world_health_organization_at_un_city

WHO launches “historic” multinational study to investigate most promising COVID-19 therapies

March 30, 2020 Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir

The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …
News
usa-4925212_640

US now leads world in COVID-19 cases as report warns it could face 80,000 deaths in four months

March 27, 2020 Medical Communications, Research and Development

The US now leads the world in total number of COVID-19 cases with more than 85,500 positives, ahead of China’s …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …
News
novartis_outside_1

Novartis reveals hard-hitting five-year data for its gene therapy Zolgensma in spinal muscular atrophy

March 25, 2020 Research and Development Novartis, Zolgensma, gene therapy, pharma, spinal muscular atrophy

Novartis has revealed five-year data on its gene therapy Zolgensma, boasting that the one-time infusion demonstrated “rapid, significant and clinically …
News
0000000_1200px-paracetamol_generico

British government protecting high demand medicine for use in COVID-19 patients

March 25, 2020 Research and Development COVID-19, china coronavirus, coronavirus

The British government has implemented new restrictions to protect high demand medicines for coronavirus patients. 80 medicines and being banned …
News
00_transportation_isolation_system_1

Results released from first clinical trial using Danoprevir to treat COVID-19

March 25, 2020 Research and Development COVID, COVID-19, Wuhan, china coronavirus, coronavirus

The first clinical trial using danoprevir (Ganovo) in treating COVID-19 has released its results, showing that it is safe and …
News

FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema

March 25, 2020 Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment

Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …
News
microsoftteams-image_1

Eyeforpharma Barcelona 2020 is now a free virtual event

March 25, 2020 Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …
News
30020836983_0c6d0e542e_b

Demand for hydroxychloroquine soars after Trump says it can treat coronavirus

March 25, 2020 Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19

President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …
News
partnership

AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal

March 25, 2020 Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma

Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …
News
screen_shot_2020-01-29_at_16

Sustainability and security: How packaging is modernising pharma

March 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …
Feature

Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone

March 24, 2020 Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma

Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026